Pharmaceutical Injections

Product Details:

Cilaric Inj 1g

Imipenem and Cilastatin Injection

Generic Name: imipenem and cilastatin sodium
Dosage Form: injection, powder, for solution

To reduce the development of drug-resistant bacteria and maintain the effectiveness of imipenem and cilastatin for injection (I.V.) and other antibacterial drugs, imipenem and cilastatin for injection (I.V.) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

For Intravenous Injection Only

Product Details:

GARIZONE 1.5 g Injection

 

POWDER FOR PREPARATION OF INJECTION SOLUTION

(Sulbactam & Cefoperazone For Injection)

 

Composition

Each Vial contains:

Sulbactam Sodium USP equivalent to Sulbactam : 500 mg

Cefoperazone Sodium USP equivalent to Cefoperazone : 1000 mg

 

Indications

The combination of Cefoperazone sodium and Sulbactam sodium is indicated for the treatment of the following infections caused by susceptible organisms.

 

Respiratory tract infections (Upper and Lower), Urinary Tract Infections, Peritonitis, Cholecystitis, Cholangitis and other intra-abdominal infections, Bacterial sinusitis, Meningitis, Skin and soft tissue infections, Bone and Joint infections, Pelvic Inflammatory disease - endometritis, gonorrhea and other infections of the genital tract.

 

Dosage and Administration

Adults:

The usual adult dose of the combination is 2 to 4 g/day (i.e, 1-2 g/day each of Cefoperazone and Sulbactam) given IV or IM in equally divided doses every 12 hours.In severe or refractory infections the daily dosage may be increased to 8g (i.e, 4g/day each of Cefoperazone and Sulbactam) given IV in equally divided doses every 12 hours. The recommended maximum daily dosage of Sulbactam is 4g (8g of the combination).Dosage regimens should be adjusted in patients with the marked decrease in renal function.

Children:

The usual dosage in children is 40-80mg/kg/day (20 to 40 mg/kg/day each of Cefoperazone and Sulbactam) every six to twelve hours. In serious or refractory infections, these dosages may be increased up to 160 mg/kg/idea of the combination. (i.e., 80 mg/kg/day each of Cefoperazone and Sulbactam) every six to twelve hours.

 

Contraindications

Allergy to Penicillin or Cephalosporin.

Presentation:

Vial of 1.5 gm with Water for Injection

Product Details:

Since the time of our conception, we have been engaged in the manufacturing of a wide range of PCD Ceftriaxone Injections. These products are tested as per the international standards of quality. The customized packaging range of these products is highly appreciated by our esteemed clients.
 
Features:

Quick response

Precise composition

Longer shelf life

Zero side effects

High purity

 
Uses:

Respiratory tract infection, such as pneumonia

Bone infection (Osteomyelitis)

Joint infection (septic arthritis)

Middle ear infection (Otitis media)

Meningitis

Irritation of the prostate (Prostatitis)

Urinary tract infection (UTI)

Skin infection, such as cellulitis

Bacterial blood poisoning (septicemia)

Heart valve infection (Endocarditis)

Gonorrhea

Syphilis

Pelvic inflammatory disease (PID)

Necrotizing fasciitis (more commonly known as "flesh-eating bacteria")

Toxic shock

 
Specification:
 

Composition: Ceftriaxone 250 mg, 500 mg and 1 gm

Additional Information:

• Item Code: Cefosal-Injections

Product Details:

We are engaged in offering our clients a superior quality range of Ceftriaxone with Sulbactam Injection. We are one of the prominent suppliers of a wide range of Pharmaceutical Drugs. Our wide range includes Capsule, Soft gels, Tablets and Syrups. These are acknowledged for salient features such as purity, environment-friendly and accurate composition. 

We are looking for franchisee of our products in MALDAH.

Product Details:

We have been known in the industry for the best quality range of Ceftriaxone Sulbactam for Injection. Keeping in mind the needs and requirements of the clients, we also have a customized packaging quantities of these products. These products are also tested as per the international standards of quality before being delivered to the esteemed clients.

Features:

• Quick response

• Precise composition

• Longer shelf life

• Zero side effects

• High purity

Uses:

• Infection of Spinal Cord or Brain due to Meningococcus

• Treatment to Prevent Meningococcal Meningitis

• Blood Infection caused by Streptococcus Bacteria

• Blood Infection caused by Staphylococcus Bacteria

• Blood Poisoning caused by Haemophilus Species Bacteria, Escherichia Coli Bacteria in the Blood

• Infection of the Blood by Klebsiella Pneumoniae Bacteria

• Blood Poisoning due to Salmonella Bacteria

• Bacterial Infection of Blood or Tissues affecting the Whole Body, Infection caused by Haemophilus Influenzae Type B Bacteria, Acute Gonorrhea of the Lower Genital and Urinary Organs

• Acute Gonorrhea of the Urethra, Acute Gonorrhea of the Cervix, Acute Gonorrhea of the Lining of the Uterus

• Conjunctivitis caused by Gonorrhea, Arthritis due to Gonococci Bacteria, Gonorrhea Infection of the Throat

• Gonorrhea of the Rectum

• Gonorrhea of the Coverings of the Brain and Spinal Cord

Additional Information:

• Item Code: Cefosal-SB-Injection

Product Details:

Esogen-40 Inj
Esomeprazole for Injection 40 Mg (Lyophilised Injection)

Description:
Esomeprazole is the S-Isomer of Omeprazole and Reduces Gastric Acid Secretion Through a Specific Targeted Mechanism of Action. It is a Specific Inhibitor of the Acid Pump in the Parietal Cell. Both the R- and S-Isomer of Omeprazole Have Similar Pharmacodynamic Activity.

Mechanism of Action:
Esomeprazole is a Weak Base and is Concentrated and Converted to the Active Form in the Highly Acidic Environment of the Secretory Canaliculi of the Parietal Cell, Where It Inhibits the Enzyme H+k+-Atpase C the Acid Pump and Inhibits Both Basal and Stimulated Acid Secretion.

Indications:
Short-Term (4-8 Weeks) Treatment of Erosive Esophagitis; Maintaining Symptom Resolution and Healing of Erosive Esophagitis; Treatment of Symptomatic Gastroesophageal Reflux Disease; As Part of a Multidrug Regimen for Helicobacter Pylori Eradication in Patients With Duodenal Ulcer Disease (Active Or History of Within the Past 5 Years); Prevention of Gastric Ulcers Associated With Continuous Nsaid Therapy.

Dosage and Administration:
The Recommended Adult Dose of Esomeprazole I.v is Either 20 Or 40 Mg Given Once Daily by Intravenous Injection (No Less Than 3 Minutes) Or Intravenous Infusion (10 to 30 Minutes). Esomeprazole I.v. Should Not Be Administered Concomitantly With Any Other Medications Through the Same Intravenous Site and Or Tubing. the Intravenous Line Should Always Be Flushed With Either 0.9% Sodium Chloride Injection, Usp, Lactated Ringer Injection, Usp Or 5% Dextrose Injection, Usp Both Prior to and After Administration of Esomeprazole I.v. for Injection.

We Are Looking for Franchise Opportunities, Business Opportunities, Pharmaceutical Distributors, Pharmaceutical Marketing Services, Pharma Pcd & Pharma Franchise.

Additional Information:

• Pay Mode Terms: T/T (Bank Transfer)
• Port of Dispatch: Chandigarh
• Packaging Details: Injection

Product Details:

Pantoprazole Sodium for Injection 40 mg (Lyophilised Injection)

PANAV-40 INJ for Injection is supplied as a freeze-dried powder in a clear glass vial fitted with a rubber stopper and crimp seal containing Pantoprazole sodium, equivalent to 40 mg of pantoprazole.

Mechanism Of Action:
Pantoprazole is a Proton Pump Inhibitor (PPI) that suppresses the final step in gastric acid production by covalently binding to the (H+, K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. This effect leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus. The binding to the (H+, K+)-ATPase results in a duration of antisecretory effect that persists longer than 24 hours for all doses tested.

INDICATIONS:
PANAV-40 INJ is indicated for the treatment of gastric ulcer, duodenal ulcer, moderate and severe reflux oesophagitis.


Dosage:
PANAV-40 INJ is recommended only in cases where the oral administration is not indicated. The recommended dose is intravenous administration of the content of one vial ( 40 mg Pantoprazole ) once daily for 7 days.

Duodenal Ulcer:
Duodenal Ulcers generally heal within 2 weeks. If a 2-week period of treatment is not sufficient, healing will be achieved in almost all cases within a further 2 weeks.

Gastric Ulcer Gastro-oesophageal reflux: A 4 week period is usually required for the treatment of gastric ulcers gastro-oesophageal reflux. If this is not sufficient, healing will usually be achieved within a further 4 weeks.

Elderly:No dose adjustment is necessary in the elders.

Patients with Impaired Renal Function:No dose adjustment is necessary in patients with impaired renal function.

Patients with Impaired Hepatic Function: In patients with severe liver impairments, the daily dose should be reduced to 20 mg Pantoprazole. Also, in these patients the liver enzymes should be monitored during PANAV-40 INJ therapy. In case of liver enzymes, it should be discontinued.

Direction For Reconstitution:
The content of the vial needs to be reconstituted with 10 ml of Sodium Chloride Injection BP 0.9% w/v before injection.

This freshly prepared solution should be administered intravenously over 2 to 15 minutes, either as a slow injection or it may be further diluted with 100 ml of Sodium Chloride Injection BP 0.9 % w/v or 5% Glucose Injection and administered as a short term infusion.

The duration of administration should be 2 to 15 minutes. The reconstituted solution must be used within 12 hours of preparation.

Adverse Effects:
Treatments with Pantoprazole can occasionally lead to headache or diarrhea. Rarely nausea/vomiting, abdominal pain, flatulence, constipation, allergic reactions such as skin rash and pruritus may occur. Individual cases of oedema, blurred vision, fever, dizziness, thrombophlebitis, depression or myalgia subsiding after termination of therapy have been reported.

Presentation:PANAV-40 INJ is available as Box of one 10 ml vial with 10 ml Sodium Chloride Injection BP as diluent.

Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. Please see your health care professional for more information about your specific medical condition and the use of the above mentioned drug.

Product Details:

PEMAX-TZ INJ 4.5G

Piperacillin Sodium and Tazobactam for Injection (4g+500mg)

Description:
Piperacillin and Tazobactam for injection is an injectable antibacterial combination product consisting of the semisynthetic antibiotic piperacillin sodium and the beta-lactamase inhibitor tazobactam sodium for intravenous administration.

Piperacillin sodium is derived from D(-)aminobenzyl-penicillin. The chemical name of piperacillin sodium is sodium (2S,5R,6R)-6-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazine-carboxamido)-2-phenylacetamido]-3,3-dimethyl-7-oxo-4-thia-1azabicyclo[3.2.0]heptane-2-carboxylate.

Tazobactam sodium, a derivative of the penicillin nucleus, is a penicillanic acid sulfone. Its chemical name is sodium (2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate-4,4-dioxide.

Mechanism Of Action:
Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin binding proteins (PBPs); which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested. Tazobactam inhibits many beta-lactamases, including staphylococcal penicillinase and Richmond and Sykes types II, III, IV, and V, including extended spectrum enzymes; it has only limited activity against class I beta-lactamases other than class Ic types.

Indications:

In adults and children over 12 years of age:

• Bacterial infections of the lungs and airways (chest or lower respiratory tract infections)
• Bacterial infections within the abdomen
• Bacterial infections of the urinary tract
• Bacterial infections of the skin
• Bacterial infections of the blood (septicaemia or blood poisoning)
• Bacterial infections in people with low white blood cell counts (neutropenia) and hence decreased ability to fight infection (used in combination with an aminoglycoside antibiotic for this purpose)

In children under 12 years of age:

• Appendicitis complicated by a burst appendix, peritonitis and/or abcess formation in children aged 2 to 12 years.
• Bacterial infections in children with low white blood cell counts (neutropenia) and hence decreased ability to fight infection (used in combination with an aminoglycoside antibiotic for this purpose)

Dosage And Administration:
PEMAX-TZ INJ 4.5G should be administered by intravenous infusion over 30 minutes.

Adults: The usual total daily dose of PEMAX-TZ INJ 4.5G is 3.375 g every six hours totaling 13.5 g (12.0 g piperacillin/1.5 g Tazobactam).
Contraindications: PEMAX-TZ INJ 4.5G is contraindicated in patients with a history of allergic reactions to any of the penicillins, cephalosporins, or beta-lactamase inhibitors.

Important: The drug information on this Web page is meant to be educational. It is not a substitute for medical advice. Please see your health care professional for more information about your specific medical condition and the use of the above mentioned drug.

Product Details:

We, Salveo Lifecare, are engaged in trading and supplying a broad range of Diclofenac Injections 75mg/ ml.